With regards to tumor stage, a 14.7% increase in patients presenting with stage III and IV cancer was found in 2020 compared to 2019, however, this difference did not reach statistical significance, likely related to limited sample size.
← all excerpts
Pancreatic Cancer Care in the Era of COVID-19: Collateral Damage of the Pandemic
1
—
—